Tailored Phototherapy Agent by Infection Site in Situ Activated against Methicillin‐Resistant S. aureus

Lixia Guo,Yafei Tian,Liang Zhou,Shiyue Kang,Chengwu Zhang,Wen Liu,Haipeng Diao,Liheng Feng
DOI: https://doi.org/10.1002/adhm.202400593
IF: 10
2024-05-11
Advanced Healthcare Materials
Abstract:Phototherapy, including photodynamic therapy (PDT) and photothermal therapy (PTT), is a promising treatment approach for multidrug resistant infections. PDT/PTT combination therapy can more efficiently eliminate pathogens without drug resistance. The key to improve the efficacy of photochemotherapy is the utilization efficiency of non‐radiation energy of phototherapy agents. Herein, we design a facile phototherapy molecule (SCy‐Le) with the enhancement of non‐radiative energy transfer by an acid stimulation under a single laser. Introduction of the protonated receptor into SCy‐Le results in a distorted intramolecular charge in the infected acidic microenvironment, pH≈5.5, which in turn enhances light capture, reduces the singlet–triplet transition energies (ΔES1‐T1), promotes electron system crossing, enhances capacity of ROS generation, and a significant increase in temperature by improving vibrational relaxation. SCy‐Le showed more than 99% bacterial killing rate against both methicillin‐resistant Staphylococcus aureus (MRSA) and its biofilms in vitro, and caused bacteria‐induced wound healing in mice. This work will provide a new perspective for the design of phototherapy agents, and the emerging photochemotherapy will a promising approach to combat the problem of antibiotic resistance. This article is protected by copyright. All rights reserved
nanoscience & nanotechnology,engineering, biomedical,materials science, biomaterials
What problem does this paper attempt to address?